Toshihiro Nukiwa

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.

A. Gemma, T. Harada, S. Oizumi, 2010, The New England journal of medicine.

Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902.

A. Gemma, T. Harada, S. Oizumi, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Total respiratory system compliance after thoracoplasty.

T. Nukiwa, K. Shiraishi, M. Motomiya, 1998, Respiratory medicine.

Retinoic acids repress the expression of ETS-1 in endothelial cells.

T. Nukiwa, M. Abe, T. Igarashi, 2001, The Tohoku journal of experimental medicine.

Chromosome band 16q24 is frequently deleted in human gastric cancer

M. Sato, A. Horii, T. Nukiwa, 1999, British Journal of Cancer.

Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung.

M. Ebina, S. Fujimura, T. Nukiwa, 2000, The American journal of pathology.

Carcinoembryonic antigen-related cell adhesion molecules as surrogate markers for EGFR inhibitor sensitivity in human lung adenocarcinoma

H. Sasano, Y. Miki, H. Kumamoto, 2012, British Journal of Cancer.

This information is current as Immune Responses Elicit Distinct Legionella pneumophila Dendritic Cells Pulsed with Live and Dead

T. Kikuchi, K. Gomi, Y. Tokue, 2004 .

Pharmacokinetic analysis of combination chemotherapy with carboplatin and etoposide in small-cell lung cancer patients undergoing hemodialysis.

T. Suzuki, M. Maemondo, T. Nukiwa, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.